logo-loader
Heritage Cannabis

Heritage Cannabis inks pact with Canntab Therapeutics for capsule manufacturing

Heritage’s subsidiary Purefarma Solutions will provide processing services for hemp supplied by Canntab for its ingestible cannabis products

Canntab hard pills
Canntab's oral delivery system treats different ailments by delivering a uniform dosage of medicinal cannabis extract

Heritage Cannabis Holdings Corp (CSE:CANN)(OTCQX: HERTF) said Thursday that it has inked a pact with Canntab Therapeutics Limited (CSE:PILL.CN) (OTCMKTS:CTABF) for capsule manufacturing.

Canntab has a Health Canada license to cultivate industrial hemp that it uses to extract cannabidiol (CBD) to manufacture cannabis pills.

According to the term sheet, Heritage’s subsidiary Purefarma Solutions will now provide processing services for hemp supplied by Canntab Therapeutics for its ingestible cannabis products.

READ: Canntab Therapeutics hits new milestone with hemp-processing licence from Health Canada

Canntab and Heritage will jointly support each other in relation to the regulatory submissions required to distribute and sell cannabis capsules.

In addition, Heritage will provide strategic support including packaging and distribution.

“Canntab has developed proprietary cannabinoid formulations, and it’s our intention to become an industry leader in oral dosage cannabis,” said Canntab CEO Jeff Renwick. “We view this partnership with Heritage and Purefarma as a critical step in our company achieving our goals.”

Canntab's oral delivery system treats different ailments by delivering a uniform dosage of medicinal cannabis extract.

The agreement will begin immediately and is open-ended subject to a 120-day cancellation notice by either party.

“This agreement with Canntab is a strategic fit for our growth as a contract service provider. It aligns with our vision to operate in final product verticals and advances our offering in the medical cannabis sector,” said Heritage Cannabis Holdings CEO Clint Sharples. “Purefarma’s extraction expertise and ability to provide quality oil is a good match for the high expectations that Canntab has for the products they will be bringing to market.”

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Quick facts: Heritage Cannabis

Price: $0.39

Market: CSE
Market Cap: $170.34 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis named herein, including the promotion by the Company of Heritage Cannabis in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Heritage Cannabis and Empower Clinics team up for production...

Heritage Cannabis (CSE: CANN) CEO Clint Sharples and Empower Clinics (CSE: CBDT) Chairman and CEO Steven McAuley join sat down with Steve Darling from Proactive Vancouver to discuss their Joint Venture for production of CBD oil at Empower’s facility in Oregon. Sharples tells Proactive how...

1 day, 5 hours ago

2 min read